Discloses BTV peptides having at least 80% identity to SEQ ID NOs: 4, 6 or 10, immunogenic fragments of said sequences that bind to antibodies that specifically bind to said sequences, and plasmids comprising DNA fragments having at least 90% identity to SEQ ID NOs: 1-3, 5 and 7-9, wherein the sequences are as defined in the complete specification.